Prescriber's Corner
Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer
Harmony J. Bowles, PharmD, and Kathryn L. Clarke, NP-C
University of Arizona Cancer Center, Tucson, Arizona
Harmony J. Bowles, PharmD, University of Arizona Cancer Center, 3838 N. Campbell Avenue, Tucson, AZ 85719.
E-mail: harmony.bowles@bannerhealth.com
doi: 10.6004/jadpro.6.6.6 |
© 2015 Harborside Press®
For access to the full length article, please
sign in.
